{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for beta root_names_name in Any Name (approximate match)
Status:
Investigational
Source:
NCT04692181: Phase 1/Phase 2 Interventional Active, not recruiting Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01097096: Phase 2 Interventional Completed Alzheimer's Disease
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03578029: Phase 2 Interventional Terminated Junctional Epidermolysis Bullosa
(2019)
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Source:
INN:metelimumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01959165: Phase 2 Interventional Completed Ulcerative Colitis
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01786096: Phase 1 Interventional Completed Burkitt Lymphoma
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01760005: Phase 2/Phase 3 Interventional Recruiting Alzheimers Disease
(2012)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01227564: Phase 2 Interventional Completed Alzheimer's Disease
(2011)
Source URL:
Class:
PROTEIN